Medication Identification and Risk Signals
Key Takeaways
- PTCB assigns Medications and Components 17% of the CSPT exam, the largest single content domain.
- Study generic and brand names, therapeutic classes, indications, routes, and high-alert patterns for the drugs that are sterile-compounded.
- High-alert and narrow therapeutic index drugs demand independent double-checks because a small preparation error can kill.
- Intrathecal and epidural routes require preservative-free components because benzyl alcohol is neurotoxic in the central nervous system.
Why medication identity matters
The CSPT (Certified Compounded Sterile Preparation Technician) exam, administered by the Pharmacy Technician Certification Board (PTCB) and delivered through Pearson VUE, does not treat drug names as trivia. The test has 75 multiple-choice questions (60 scored plus 15 unscored pretest items) in a 1-hour-50-minute session, costs $149, and is scored on a 1,000 to 1,600 scale with a passing scaled score of 1,400. The Medications and Components domain is the single largest, at 17% of the exam.
A technician must connect a drug name to its class, sterile dosage form, route, storage limits, and harm potential, because that recognition drives every check before compounding and every escalation to the pharmacist.
What to know for each medication
| Item | CSPT focus |
|---|---|
| Generic and brand names | Prevent look-alike/sound-alike (LASA) confusion |
| Therapeutic class | Predict usual purpose and safety concerns |
| Indication | Check whether the order makes clinical sense |
| Major side effects | Recognize why dose and route errors matter |
| Dosage form and strength | Match vial, bag, syringe, or diluent to the order |
| Route | Apply route-specific sterility, labeling, and preservative limits |
Look-alike/sound-alike (LASA) pairs are a recurring exam theme: vincristine vs. vinblastine, hydromorphone vs. morphine, heparin vs. Hespan, and cefazolin vs. cefepime. Tall-man lettering (e.g., DOPamine vs. DOBUTamine, vinBLAStine vs. vinCRIStine) and barcode scanning are the standard defenses. When two vials look identical at the hood, the technician slows down and verifies the NDC (National Drug Code), concentration, and total drug, not the cap color.
High-alert and NTI patterns
High-alert medications are drugs where an error is more likely to cause significant patient harm. Narrow therapeutic index (NTI) medications have a small margin between the effective and toxic dose. Some drugs are both.
The Institute for Safe Medication Practices (ISMP) high-alert parenteral list includes: insulin; heparin and other anticoagulants; concentrated electrolytes (potassium chloride, potassium phosphate, hypertonic saline above 0.9%, magnesium sulfate); chemotherapy/antineoplastics; opioids (morphine, hydromorphone, fentanyl); neuromuscular blockers (rocuronium, vecuronium, succinylcholine); and parenteral nutrition.
The technician's response is not memory-guessing; it is an independent double-check, exact unit handling, clear labeling, barcode verification, and prompt escalation when an order or component does not match expectations.
Trap: Concentrated potassium chloride for injection must never reach a final container without verification — undiluted KCl pushed IV is fatal. The exam often pairs a "hurry up" scenario with a high-alert drug to test whether you stop for the double-check.
Dosage forms and routes
Sterile compounding covers far more than IV bags. Compounded sterile preparations (CSPs) include:
- IV bolus (push) doses and intermittent (piggyback) infusions
- Continuous infusions and large-volume parenterals (LVPs)
- Syringes and elastomeric (ambulatory) pumps
- Ophthalmic drops and irrigations
- Epidural and intrathecal preparations
- Total parenteral nutrition (TPN/PN) admixtures and 3-in-1 emulsions
- IM and subcutaneous depot preparations
Route changes the acceptable component. Intrathecal (into spinal fluid) and epidural preparations require preservative-free components — benzyl alcohol, the common preservative in bacteriostatic water and saline, is neurotoxic in the central nervous system. Ophthalmic preparations must be sterile, isotonic where possible, and low in particulates because ocular tissue irritates easily. The exam expects you to flag a preserved diluent ordered for an intrathecal dose.
Common sterile drug classes and their identity cues
| Class | Example agents | Identity/safety cue |
|---|---|---|
| Beta-lactam antibiotics | cefazolin, piperacillin-tazobactam | Sensitizers when handled dry; verify diluent volume and reconstitution |
| Glycopeptides | vancomycin | Dilute to no more than 5 mg/mL peripherally; slow infusion |
| Anticoagulants | heparin, enoxaparin, argatroban | High-alert; units vs. mg vs. mcg/kg/min confusion is a leading error |
| Electrolytes | KCl, magnesium sulfate, calcium gluconate | Concentrated forms high-alert; verify mEq vs. mL |
| Antineoplastics | cyclophosphamide, doxorubicin, paclitaxel | NIOSH hazardous; require negative-pressure containment |
| Vasoactives | norepinephrine, dopamine, dobutamine | LASA, concentration-sensitive; tall-man lettering applies |
| Opioids | morphine, hydromorphone, fentanyl | High-alert, controlled; morphine/hydromorphone are dangerous LASA |
Worked identity check
An order reads: "Vancomycin 1.25 g in 250 mL NS, infuse over 90 min." The vials on hand are 500 mg. The technician reasons: 1.25 g = 1,250 mg, so 2.5 vials are needed, and the final concentration is 1,250 mg / 250 mL = 5 mg/mL (the peripheral ceiling). Vancomycin is typically infused no faster than about 10 mg/min to avoid an infusion reaction. A 90-minute run for 1,250 mg is roughly 14 mg/min — faster than the guideline — so the technician confirms the rate with the pharmacist before releasing the CSP.
Connecting the name to its class, concentration limit, and rate is exactly the recognition the CSPT tests; the calculation alone is not enough.
Where escalation is mandatory
The technician handles routine compounding, but certain triggers require stopping and calling the pharmacist before any product is released: a missing or ambiguous concentration, route, or rate; a high-alert drug dosed outside usual limits; a component that does not match the order (wrong salt, wrong preservative status, wrong diluent); any visible defect in a vial or finished CSP; and any look-alike substitution that barcode and NDC verification cannot resolve. On the exam, the safest answer to "the order is unclear" or "the component seems wrong" is almost always to verify and escalate — never to assume intent or substitute on your own.
A technician sees an order for a preservative-free morphine preparation intended for intrathecal administration. Which safety concern is most specific to that route?
While verifying components, a technician finds two adjacent vials labeled DOBUTamine and DOPamine. Which combination of practices best defends against a mix-up?